Ident. | Authors (with country if any) | Title |
---|
000196 (2018) |
Irina V. Ilyina [Russie] ; Vladimir V. Zarubaev [Russie] ; Irina N. Lavrentieva [Russie] ; Anna A. Shtro [Russie] ; Iana L. Esaulkova [Russie] ; Dina V. Korchagina [Russie] ; Sophia S. Borisevich [Russie] ; Konstantin P. Volcho [Russie] ; Nariman F. Salakhutdinov [Russie] | Highly potent activity of isopulegol-derived substituted octahydro-2H-chromen-4-ols against influenza A and B viruses. |
000743 (2014) |
Wael M. Abdel-Mageed [Égypte] ; Soad A H. Bayoumi [Égypte] ; Caixia Chen [République populaire de Chine] ; Christopher J. Vavricka [République populaire de Chine] ; Li Li [République populaire de Chine] ; Ajamaluddin Malik [Arabie saoudite] ; Huanqin Dai [République populaire de Chine] ; Fuhang Song [République populaire de Chine] ; Luoqiang Wang [République populaire de Chine] ; Jingyu Zhang [République populaire de Chine] ; George F. Gao [République populaire de Chine] ; Yali Lv [République populaire de Chine] ; Lihong Liu [République populaire de Chine] ; Xueting Liu [République populaire de Chine] ; Hanaa M. Sayed [Égypte] ; Lixin Zhang [République populaire de Chine] | Benzophenone C-glucosides and gallotannins from mango tree stem bark with broad-spectrum anti-viral activity. |
000915 (2013) |
Takayuki Komatsu [Japon] ; Nobuo Kido ; Tsuyoshi Sugiyama ; Takashi Yokochi | Antiviral activity of acidic polysaccharides from Coccomyxa gloeobotrydiformi, a green alga, against an in vitro human influenza A virus infection. |
000E68 (2010) |
Katrina Sleeman [États-Unis] ; Vasiliy P. Mishin ; Varough M. Deyde ; Yousuke Furuta ; Alexander I. Klimov ; Larisa V. Gubareva | In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses. |
001270 (2008) |
Antonios Kolocouris [Grèce] ; Philip Spearpoint ; Stephen R. Martin ; Alan J. Hay ; Marta L Pez-Querol ; Francesc X. Sureda ; Elizaveta Padalko ; Johan Neyts ; Erik De Clercq | Comparisons of the influenza virus A M2 channel binding affinities, anti-influenza virus potencies and NMDA antagonistic activities of 2-alkyl-2-aminoadamantanes and analogues. |
001373 (2007) |
Fred Y. Aoki [Canada] ; Guy Boivin ; Noel Roberts | Influenza virus susceptibility and resistance to oseltamivir. |
001574 (2005) |
I A Leneva ; I T Fediakina ; T A Gus'Kova ; R G Glushkov | [Sensitivity of various influenza virus strains to arbidol. Influence of arbidol combination with different antiviral drugs on reproduction of influenza virus A]. |
001646 (2005) |
Takashi Suzuki [Japon] ; Tadanobu Takahashi [Japon] ; Chao-Tan Guo [Japon, République populaire de Chine] ; Kazuya I.-P. Jwa Hidari [Japon] ; Daisei Miyamoto [Japon] ; Hideo Goto [Japon] ; Yoshihiro Kawaoka [Japon, États-Unis] ; Yasuo Suzuki [Japon] | Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication |
001738 (2003) |
Grigoris Zoidis [Grèce] ; Nicolas Kolocouris [Grèce] ; George B. Foscolos [Grèce] ; Antonios Kolocouris [Grèce] ; George Fytas [Grèce] ; P. Karayannis [Grèce] ; Elizaveta Padalko [Belgique] ; Johan Neyts [Belgique] ; Erik De Clercq [Belgique] | Are the 2-isomers of the drug rimantadine active anti-influenza A agents? |
001751 (2002) |
Christoph Scholtissek ; Jürgen Stech ; Scott Krauss ; Robert G. Webster | Cooperation between the Hemagglutinin of Avian Viruses and the Matrix Protein of Human Influenza A Viruses |
001978 (1999) |
F. Li [République populaire de Chine] ; Q J Wang ; B L Zhu ; M. Wang | Antiviral effects of rhIFN-alpha 1 against seven influenza viruses. |
001984 (1999) |
Antonios Kolocouris [Grèce] ; Dimitrios Tataridis [Grèce] ; George Fytas [Grèce] ; Thomas Mavromoustakos [Grèce] ; George B. Foscolos [Grèce] ; Nicolas Kolocouris [Grèce] ; Erik De Clercq [Belgique] | Synthesis of 2-(2-adamantyl)piperidines and structure anti-influenza virus a activity relationship study using a combination of NMR spectroscopy and molecular modeling |
001994 (1999) |
Jon D. Reuter [États-Unis] ; Andrzej Myc [États-Unis] ; Michael M. Hayes [États-Unis] ; Zhonghong Gan [États-Unis] ; Rene Roy [États-Unis] ; Dujie Qin [États-Unis] ; Rui Yin [États-Unis] ; Lars T. Piehler [États-Unis] ; Roseita Esfand [États-Unis] ; Donald A. Tomalia [États-Unis] ; James R. Baker [États-Unis] | Inhibition of Viral Adhesion and Infection by Sialic-Acid-Conjugated Dendritic Polymers |
001A38 (1999) |
M. Kobayashi [États-Unis] ; S. M. Davis [États-Unis] ; T. Utsunomiya [États-Unis] ; R. B. Pollard [États-Unis] ; F. Suzuki [États-Unis] | Antiviral effect of gingyo-san, a traditional chinese herbal medicine, on influenza A2 virus infection in mice |
001A44 (1998) |
Daisei Miyamoto [Japon] ; Yuki Kusagaya [Japon] ; Naoko Endo [Japon] ; Ayako Sometani [Japon] ; Seiji Takeo [Japon] ; Takashi Suzuki [Japon] ; Yaeno Arima [Japon] ; Katsuyuki Nakajima [États-Unis] ; Yasuo Suzuki [Japon] | Thujaplicin–copper chelates inhibit replication of human influenza viruses |
001B04 (1998) |
C. Scholtissek [États-Unis] ; G. Quack [Allemagne] ; H. D Klenk [Allemagne] ; R. G Webster [États-Unis] | How to overcome resistance of influenza A viruses against adamantane derivatives |
001B19 (1998) |
K. Sato [Japon] ; M. Suga [Japon] ; T. Akaike [Japon] ; S. Fujii [Japon] ; H. Muranaka [Japon] ; T. Doi [Japon] ; H. Maeda [Japon] ; M. Ando [Japon] | Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice |
001B20 (1998) |
S. Bantia [États-Unis] ; A. A. Ghate [États-Unis] ; S. L. Ananth [États-Unis] ; Y. Sudhakar Babu [États-Unis] ; G. M. Air [États-Unis] ; G. M. Walsh [États-Unis] | Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140 |
001B24 (1997) |
O. Andersen [Danemark] ; K. Vilsgaard Ravn ; I. Juul S Rensen ; G. Jonson ; E. Holm Nielsen ; S E Svehag | Serum amyloid P component binds to influenza A virus haemagglutinin and inhibits the virus infection in vitro. |
001C03 (1996) |
E H Nasser [États-Unis] ; A K Judd ; A. Sanchez ; D. Anastasiou ; D J Bucher | Antiviral activity of influenza virus M1 zinc finger peptides. |
002139 (1989) |
H. Aso [Japon] ; F. Suzuki ; T. Ebina ; N. Ishida | Antiviral activity of carboxyethylgermanium sesquioxide (Ge-132) in mice infected with influenza virus. |
002270 (1988) |
R. B. Belshe ; M. Hall Smith ; C. B. Hall ; R. Betts ; A. J. Hay | Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection |
002561 (1983) |
R. Mentel ; B. Helbig ; R. Klöcking ; L. Döhner ; M. Sprössig | [Effectiveness of phenol body polymers against influenza virus A/Krasnodar/101/59/H2N2]. |
002633 (1982) |
L M Garmashova ; G F Leontieva ; Dubrovina TYa ; G I Aleksandrova | Partial change of the ts-phenotype of cold-adapted influenza virus strain grown in canine kidney cells in the presence of trypsin. |
002859 (1980) |
J. Drescher [Allemagne] ; U. Desselberger [Allemagne] | Antineuraminidase antibody response to vaccination of chickens with intact virus and different subunit preparations of the influenza virus strains A/Sing/1/57 (H2N2), A/Hong Kong/1/68 (H3N2) and A/Port Chalmers/1/73 (H3N2) |
002A85 (1977) |
Margaret Tisdale [Royaume-Uni] ; D. J. Bauer [Royaume-Uni] | THE RELATIVE POTENCIES OF ANTI‐INFLUENZA COMPOUNDS |
002A91 (1977) |
U. Desselberger [Allemagne] | Preparation-conditioned changes of the antigenicity of influenza virus neuraminidases |
002A96 (1977) |
Fujio Suzuki [Japon] ; Noriyuki Saito [Japon] ; Nakao Ishida [Japon] | EFFECT OF AN INTERFERON INDUCER, 9‐METHYLSTREPTIMIDONE, ON INFLUENZA VIRUS INFECTION IN MICE |
002D71 (????) |
G V Kornilaeva ; E V Molibog ; A G Bukrinskaia | [pH-dependent hemolytic and neuraminidase activity of remantadine-sensitive and -resistant variants of influenza virus]. |
002D77 (????) |
S G Markushin ; B V Sinitsyn ; V P Ginzburg ; A M Kha Der ; A I Klimov | [The mechanisms of the antiviral action of the bora-adamantane derivative preparation BG-12]. |
002D98 (????) |
G M Vode Ko ; L A Zazimko ; V R Farashian ; V M Zhdanov | [Parent and recombinant influenza virus A strains differing in the degree of remantadine sensitivity]. |